CLASS II ONGOING Device recall · Reported 1 May 2024 · FDA Enforcement Report

Redux Electrolyte Creme, Product recalled by Parker Laboratories

Parker Laboratories is recalling Redux Electrolyte Creme, Product, distributed nationwide in the US. The recall was initiated on 22 Mar 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesProduct No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).
Quantity recalled217 cases (1,085 Inner Boxes; 10,850 Eaches)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1604-2024
FDA event ID
94303
Recalling firm
Parker Laboratories, Fairfield, NJ
Classification
Class II
Status
Ongoing
Recall initiated
22 Mar 2024
FDA classified
19 Apr 2024
Reported
1 May 2024
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

22 Mar 2024Recall initiated by company
19 Apr 2024Classified by FDA+28 days
1 May 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product demonstrates low viscosity.

Product as listed by the FDA

Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.

Where it was distributed

Worldwide distribution - US Nationwide in the states of CA, CO, FL, GA, IL, MD, MI, MN, NC, NE, NY, OH, PA, SC, & TX. The countries of AU, CA, OM, & SA.

Nationwide CaliforniaColoradoFloridaGeorgiaIllinoisMarylandMichiganMinnesotaNorth CarolinaNebraskaNew YorkOhioPennsylvaniaSouth CarolinaTexas

Questions about this recall

Why was it recalled?

Product demonstrates low viscosity.

Which lots are affected?

Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).

Where was it sold?

Worldwide distribution - US Nationwide in the states of CA, CO, FL, GA, IL, MD, MI, MN, NC, NE, NY, OH, PA, SC, & TX. The countries of AU, CA, OM, & SA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Parker Laboratories

All 9

Other Other Medical Devices recalls

All 13,857